STERIS plc (STE)

Revenue by Geography

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
Ireland Revenue	108.50M	107.32M
Ireland Revenue Growth	1.10%	29.78%
United States Revenue	4.33B	4.01B
United States Revenue Growth	8.14%	6.83%
Other Locations Revenue	1.49B	1.34B
Other Locations Revenue Growth	11.09%	3.07%
Revenue (Other)	-100.00K	-11.00K
Revenue (Total)	5.94B	5.46B
Revenue (Total) Growth	8.73%	6.24%

Revenue

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
Healthcare Revenue	4.21B	3.88B
Healthcare Revenue Growth	8.51%	7.35%
Applied Sterilization Technologies Revenue	1.14B	1.04B
Applied Sterilization Technologies Revenue Growth	9.62%	8.87%
Life Sciences Revenue	588.80M	542.27M
Life Sciences Revenue Growth	8.58%	-5.15%
Revenue (Other)	-	-11.00K
Revenue (Total)	5.94B	5.46B
Revenue (Total) Growth	8.73%	6.24%

EBIT

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
Healthcare Operating Income	1.04B	971.52M
Healthcare Operating Income Growth	6.68%	11.49%
Applied Sterilization Technologies Operating Income	524.70M	465.58M
Applied Sterilization Technologies Operating Income Growth	12.70%	5.87%
Life Sciences Operating Income	251.00M	229.44M
Life Sciences Operating Income Growth	9.40%	3.66%
Operating Income (Other)	-710.30M	-799.94M
Operating Income (Total)	1.10B	866.60M
Operating Income (Total) Growth	27.14%	3.65%

Key Performance Indicators

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019	Mar 31, 2018	Mar 31, 2017	Mar 31, 2016	Mar 31, 2015	Mar 31, 2014	Mar 31, 2013
Constant Currency Organic Revenue Growth	7.30%	6.20%

Data Source: Fiscal.ai Last updated: May 11, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 2, 2026

Data Sources Report a data error